Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance coverage. Because of these barriers, many people are doing an end-run around their doctor’s office, reaching out to potentially unreliable sources that promise to set them up with the… read on > read on >
That plastic wrap you find around the food you eat is far from benign: A new study shows that more than 3,600 chemicals leach into food during the packaging process. Of that number, 79 chemicals are known to cause cancer, genetic mutations, and endocrine and reproductive issues, a team of international researchers reported Tuesday in the Journal… read on > read on >
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liver disease (MASLD) were 14% less likely to progress to cirrhosis if they’d… read on > read on >
Beans may sometimes give you gas, but one expert says that shouldn’t stop you from finding ways to include them in your diet. Why? Because they are packed with nutrients that contribute to good health. “Beans are in a unique category because they are a protein source, but they are also complex carbohydrates,” said Dr.… read on > read on >
Boar’s Head announced Friday that its Jarratt, Va. deli meat manufacturing plant, found to be the source of a deadly outbreak of listeria infections, will be closed indefinitely. Boar’s Head added that it also believes it has located the source of contamination. “Our investigation has identified the root cause of the contamination as a specific… read on > read on >
Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds. Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of people being treated for obesity and 23% being treated for diabetes after a… read on > read on >
Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce the amount of daily insulin they needed, researchers reported Thursday at the European… read on > read on >
Excessive time spent on social media increases children’s and teens’ risk of developing an eating disorder, a new study warns. Each additional hour of total screen time or social media use raises the likelihood that a kid or young teen will have eating disorder symptoms two years later, researchers reported recently in the journal Eating… read on > read on >
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows. In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distinction, according to data… read on > read on >
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. But women lost up to 25% of their initial body weight when treated… read on > read on >
